Sign in →

Test Code PSAFT Prostate-Specific Antigen (PSA), Total and Free, Serum

Additional Codes

Mayo Test ID COPIA Test Code EPIC Test Codes
PSAFT PSAFT-PSA Total & Free, S

LAB0212902

PSA, TOTAL AND FREE

 

Reporting Name

PSA Total and Free, S

Useful For

As an aid in distinguishing prostate cancer from benign prostatic conditions in men aged 50 years and older with total PSA between 4.0 and 10.0 ng/mL with digital rectal examination findings that are not suspicious for cancer

Testing Algorithm

Total prostate-specific antigen (PSA) and free PSA are performed and reported on every specimen.

 

If the initial total PSA concentration is between 4.0 and 10.0 ng/mL, then the percent free PSA result will be calculated and reported.

Method Name

Electrochemiluminescent Immunoassay (ECLIA)

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

Serum


Ordering Guidance


This test may be ordered for patients undergoing evaluation of suspicion of prostate cancer, or for assessing the risk of prostate cancer in patients with borderline or moderately increased total prostate-specific antigen (4.0-10.0 ng/mL).



Necessary Information


Include patient's age.



Specimen Required


Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial within 3 hours of collection.


Specimen Minimum Volume

0.75 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Frozen (preferred) 90 days
  Refrigerated  72 hours

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Gross icterus Reject

Day(s) Performed

Monday through Saturday

CPT Code Information

84153

84154

LOINC Code Information

Test ID Test Order Name Order LOINC Value
PSAFT PSA Total and Free, S 53764-7

 

Result ID Test Result Name Result LOINC Value
TPSA Total PSA 83112-3
FPSA Free PSA 83113-1
PSA_R Free PSA/PSA Ratio 12841-3

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

Report Available

1 to 3 days

Forms

If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:

-General Request (T239)

-Oncology Test Request (T729)